• No results found

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 2 pagina )

Hele tekst

(1)

University of Groningen

Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for

MDR Tuberculosis

Dijkstra, Jacob Albert

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Dijkstra, J. A. (2017). Exploring strategies to individualize treatment with aminoglycosides and

co-trimoxazole for MDR Tuberculosis. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Referenties

Download het nu ( PDF - 2 pagina - 216.14 KB )

GERELATEERDE DOCUMENTEN

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

The lower LLOQ of amikacin and the ability to analyze kanamycin makes the LC-MS/MS method the preferred method for analyzing these

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

Available serum patient samples with different concentrations kanamycin were analysed with the modified immunoassay method and a previously described LC-MS/MS method.. 8

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

This model in combination with the limited sampling strategy developed can be used in daily routine to guide dosing but also to assess AUC 0-24h in phase III

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

Patients with culture-confirmed multi- or extensively drug resistant tuberculosis (MDR/ XDR-TB) receiving amikacin or kanamycin as part of their TB treatment for at least 3 days were

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

Sulfamethoxazole-N-acetyl was quantified using sulfamethoxazole-N-acetyl-D4 and trimethoprim-D9 was used as internal standard for the trimethoprim quantification.. The internal

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

were calculated based on these eight curves and compared to the pharmacokinetic parameters in the model of the earlier retrospective study.. Bland-Altman plot

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Co-trimoxazole in Patients with Tuberculosis In preparation J.A.. van der

University of Groningen Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis Dijkstra, Jacob Albert

Monte Carlo simulations resulted in limited sampling strategies 2 and 3 hours post-dose (R2 = 0.61, prediction bias = 0.16%, RMSE: 1.5%), while linear regression resulted in a